RICCHETTI INCORPORATED for EISAI, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs; Issues related to CMS rule "Medicare Coverage of Innovative Technology (MCIT)" and definition of "reasonable and necessary"; Drug pricing and access, and Medicare and Medicaid reimbursement; Issues related to pharmaceutical industry, generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Medicare/Medicaid MMM
Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs; Issues related to CMS rule "Medicare Coverage of Innovative Technology (MCIT)" and definition of "reasonable and necessary"; Drug pricing and access, and Medicare and Medicaid reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.